Autologous stem cell transplantation in patients who object to a blood transfusion: contribution of new pharmacological haematopoiesis support. (ανοίγει νέο παράθυρο)

Al-Nawakil C, Quarre MC, Heshmati F, Deau B, Park S, Dreyfus F, Bouscary D, Tamburini J.

Πηγή‎: Br J Haematol 2013;161(5):738-40.

Καταχώριση‎: PubMed 23480574

DOI‎: 10.1111/bjh.12284

https://www.ncbi.nlm.nih.gov/pubmed/23480574 (ανοίγει νέο παράθυρο)

A multicenter study of romiplostim for chemotherapy-induced thrombocytopenia in solid tumors and hematologic malignancies. (ανοίγει νέο παράθυρο)

Al-Samkari H, Parnes AD, Goodarzi K, Weitzman JI, Connors JM, Kuter DJ

Πηγή‎: Haematologica 2021;106(4):1148-57.

Καταχώριση‎: PubMed 32499239

DOI‎: 10.3324/haematol.2020.251900

https://www.ncbi.nlm.nih.gov/pubmed/32499239 (ανοίγει νέο παράθυρο)

The effect of interleukin 11 on thrombocytopenia associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia. (ανοίγει νέο παράθυρο)

Aribi A, Kantarjian H, Koller C, Thomas D, Faderl S, Garcia-Manero G, Cortes J.

Πηγή‎: Cancer 2008;113(6):1338-43.

Καταχώριση‎: PubMed 18629842

DOI‎: 10.1002/cncr.23718

https://www.ncbi.nlm.nih.gov/pubmed/18629842 (ανοίγει νέο παράθυρο)

Romiplostim efficacy in an acute myeloid leukemia patient with transfusion refractory thrombocytopenia. (ανοίγει νέο παράθυρο)

Berthelot-Richer M, Boilard B, Morin A, Bolduc B, Beauregard P, Kotb R.

Πηγή‎: Transfusion 2012;52(4):739-41.

Καταχώριση‎: PubMed 22082044

DOI‎: 10.1111/j.1537-2995.2011.03382.x

https://www.ncbi.nlm.nih.gov/pubmed/22082044 (ανοίγει νέο παράθυρο)

The role of interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with solid tumors, lymphoma, acute myeloid leukemia and bone marrow failure syndromes. (ανοίγει νέο παράθυρο)

Bhatia M, Davenport V, Cairo MS.

Πηγή‎: Leuk Lymphoma 2007;48(1):9-15.

Καταχώριση‎: PubMed 17325843

DOI‎: 10.1080/10428190600909115

https://www.ncbi.nlm.nih.gov/pubmed/17325843 (ανοίγει νέο παράθυρο)

Results of a phase I dose escalation study of eltrombopag in patients with advanced soft tissue sarcoma receiving doxorubicin and ifosfamide. (ανοίγει νέο παράθυρο)

Chawla SP, Staddon A, Hendifar A, Messam CA, Patwardhan R, Kamel YM.

Πηγή‎: BMC Cancer 2013;13:121.

Καταχώριση‎: PubMed 23497336

DOI‎: 10.1186/1471-2407-13-121

https://www.ncbi.nlm.nih.gov/pubmed/23497336 (ανοίγει νέο παράθυρο)

Efficacy of romiplostim in the treatment of chemotherapy induced thrombocytopenia (CIT) in a patient with mantle cell lymphoma. (ανοίγει νέο παράθυρο)

Demeter J, Istenes I, Fodor A, Paksi M, Dombi P, Valasinyószki E, Csomor J, Matolcsy A, Nagy ZG.

Πηγή‎: Pathol Oncol Res 2011;17(1):141-3.

Καταχώριση‎: PubMed 20628840

DOI‎: 10.1007/s12253-010-9276-4

https://www.ncbi.nlm.nih.gov/pubmed/20628840 (ανοίγει νέο παράθυρο)

Eltrombopag for radiation-induced thrombocytopenia in a glioblastoma patient. (ανοίγει νέο παράθυρο)

Duic JP, Grewal J, McConie K, Staszewski H, Haas J, Kesari S.

Πηγή‎: J Neurooncol 2012;106(2):427-9.

Καταχώριση‎: PubMed 21833801

DOI‎: 10.1007/s11060-011-0675-5

https://www.ncbi.nlm.nih.gov/pubmed/21833801 (ανοίγει νέο παράθυρο)

Recombinant human interleukin 11 and bacterial infection in patients with haematological malignant disease undergoing chemotherapy: a double-blind placebo-controlled randomised trial. (ανοίγει νέο παράθυρο)

Ellis M, Zwaan F, Hedström U, Poynton C, Kristensen J, Jumaa P, Wassell J, al-Ramadi B.

Πηγή‎: Lancet 2003;361(9354):275-80.

Καταχώριση‎: PubMed 12559860

https://www.ncbi.nlm.nih.gov/pubmed/12559860 (ανοίγει νέο παράθυρο)

Autologous stem-cell transplantation without hematopoietic support for the treatment of hematologic malignancies in Jehovah's Witnesses. (ανοίγει νέο παράθυρο)

Ford PA, Grant SJ, Mick R, Keck G.

Πηγή‎: J Clin Oncol 2015;33(15):1674-9.

Καταχώριση‎: PubMed 25870085

DOI‎: 10.1200/JCO.2014.57.9912

https://www.ncbi.nlm.nih.gov/pubmed/25870085 (ανοίγει νέο παράθυρο)

Effect of avatrombopag in the management of severe and refractory chemotherapy-induced thrombocytopenia (CIT) in patients with solid tumors. (ανοίγει νέο παράθυρο)

Gao Y, Liu Q, Shen Y, Li Y, Shao K, Ye B, Shen Y, Zhou Y, Wu D

Πηγή‎: Platelets. 2022 3;33(7):1024-1030.

Καταχώριση‎: PubMed 35040375

DOI‎: 10.1080/09537104.2022.2026910

https://pubmed.ncbi.nlm.nih.gov/35040375/ (ανοίγει νέο παράθυρο)

Results of a randomized, double-blind study of romiplostim versus placebo in patients with low/intermediate-1-risk myelodysplastic syndrome and thrombocytopenia. (ανοίγει νέο παράθυρο)

Giagounidis A, Mufti GJ, Fenaux P, Sekeres MA, Szer J, Platzbecker U, Kuendgen A, Gaidano G, Wiktor-Jedrzejczak W, Hu K, Woodard P, Yang AS, Kantarjian HM.

Πηγή‎: Cancer 2014;120(12):1838-46.

Καταχώριση‎: PubMed 24706489

DOI‎: 10.1002/cncr.28663

https://www.ncbi.nlm.nih.gov/pubmed/24706489 (ανοίγει νέο παράθυρο)

A randomized controlled trial of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving decitabine. (ανοίγει νέο παράθυρο)

Greenberg PL, Garcia-Manero G, Moore M, Damon L, Roboz G, Hu K, Yang AS, Franklin J.

Πηγή‎: Leuk Lymphoma 2013;54(2):321-8.

Καταχώριση‎: PubMed 22906162

DOI‎: 10.3109/10428194.2012.713477

https://www.ncbi.nlm.nih.gov/pubmed/22906162 (ανοίγει νέο παράθυρο)

Thrombopoietin-receptor agonists in haematological disorders: the Danish experience. (ανοίγει νέο παράθυρο)

Gudbrandsdottir S, Frederiksen H, Hasselbalch H.

Πηγή‎: Platelets 2012;23(6):423-9.

Καταχώριση‎: PubMed 22185370

DOI‎: 10.3109/09537104.2011.634931

https://www.ncbi.nlm.nih.gov/pubmed/22185370 (ανοίγει νέο παράθυρο)

Recombinant human thrombopoietin promotes platelet engraftment after haploidentical hematopoietic stem cell transplantation: a prospective randomized controlled trial. (ανοίγει νέο παράθυρο)

Han TT, Xu LP, Liu DH, Liu KY, Wang FR, Wang Y, Yan CH, Chen YH, Sun YQ, Ji Y, Wang JZ, Zhang XH, Huang XJ.

Πηγή‎: Ann Hematol 2015;94(1):117-28.

Καταχώριση‎: PubMed 25069650

DOI‎: 10.1007/s00277-014-2158-1

https://www.ncbi.nlm.nih.gov/pubmed/25069650 (ανοίγει νέο παράθυρο)

The non-peptide thrombopoietin receptor agonist eltrombopag stimulates megakaryopoiesis in bone marrow cells from patients with relapsed multiple myeloma. (ανοίγει νέο παράθυρο)

Jeong JY, Levine MS, Abayasekara N, Berliner N, Laubach J, Vanasse GJ.

Πηγή‎: J Hematol Oncol 2015;8:37.

Καταχώριση‎: PubMed 25886818

DOI‎: 10.1186/s13045-015-0136-2

https://www.ncbi.nlm.nih.gov/pubmed/25886818 (ανοίγει νέο παράθυρο)

Safety and efficacy of romiplostim in patients with lower-risk myelodysplastic syndrome and thrombocytopenia. (ανοίγει νέο παράθυρο)

Kantarjian H, Fenaux P, Sekeres MA, Becker PS, Boruchov A, Bowen D, Hellstrom-Lindberg E, Larson RA, Lyons RM, Muus P, Shammo J, Siegel R, Hu K, Franklin J, Berger DP.

Πηγή‎: J Clin Oncol 2010;28(3):437-44.

Καταχώριση‎: PubMed 20008626

DOI‎: 10.1200/JCO.2009.24.7999

https://www.ncbi.nlm.nih.gov/pubmed/20008626 (ανοίγει νέο παράθυρο)

The use of simple patient blood management strategies as an alternative to platelet and red cell transfusion in autologous stem cell transplant. (ανοίγει νέο παράθυρο)

Locantore-Ford P, Grant SJ, Keck G.

Πηγή‎: Blood 2013;122(21):2140.

https://www.bloodjournal.org/content/122/21/2140 (ανοίγει νέο παράθυρο)

The effect of recombinant human erythropoietin on platelet counts is strongly modulated by the adequacy of iron supply. (ανοίγει νέο παράθυρο)

Loo M, Beguin Y.

Πηγή‎: Blood 1999;93(10):3286-93.

Καταχώριση‎: PubMed 10233880

https://www.ncbi.nlm.nih.gov/pubmed/10233880 (ανοίγει νέο παράθυρο)

A single center experience with romiplostim for the management of chemotherapy-induced thrombocytopenia. (ανοίγει νέο παράθυρο)

Miao J, Leblebjian H, Scullion B, Parnes A

Πηγή‎: Am J Hematol 2018;93(4):E86-E88.

Καταχώριση‎: PubMed 29274130

DOI‎: 10.1002/ajh.25022

https://www.ncbi.nlm.nih.gov/pubmed/29274130 (ανοίγει νέο παράθυρο)

Pharmacological therapies to minimise platelet transfusion. (ανοίγει νέο παράθυρο)

Norfolk DR, Seghatchian J.

Πηγή‎: Transfus Sci 2000;22(3):149-53.

Καταχώριση‎: PubMed 10831916

https://www.ncbi.nlm.nih.gov/pubmed/10831916 (ανοίγει νέο παράθυρο)

Romiplostim for management of chemotherapy-induced thrombocytopenia. (ανοίγει νέο παράθυρο)

Parameswaran R, Lunning M, Mantha S, Devlin S, Hamilton A, Schwartz G, Soff G.

Πηγή‎: Support Care Cancer 2014;22(5):1217-22.

Καταχώριση‎: PubMed 24414994

DOI‎: 10.1007/s00520-013-2074-2

https://www.ncbi.nlm.nih.gov/pubmed/24414994 (ανοίγει νέο παράθυρο)

Eltrombopag for the treatment of thrombocytopenia in patients with malignant and non-malignant hematologic disorders. (ανοίγει νέο παράθυρο)

Pathak S, Roth M, Verma A, Steidl U.

Πηγή‎: Expert Opin Drug Metab Toxicol 2013;9(12):1667-75.

Καταχώριση‎: PubMed 24215532

DOI‎: 10.1517/17425255.2013.858119

https://www.ncbi.nlm.nih.gov/pubmed/24215532 (ανοίγει νέο παράθυρο)

High-dose chemotherapy without transfusion for Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in two Jehovah's Witnesses patients: a feasible option in the age of hematopoietic growth factors. (ανοίγει νέο παράθυρο)

Perol L, Grignano E, Contejean A, Gastaud L, Legoff M, Franchi P, Deau-Fischer B, Willems L, Bouscary D, Tamburini J

Πηγή‎: Leuk Lymphoma. 2019;60(9):2324-7.

Καταχώριση‎: PubMed 30773115

DOI‎: 10.1080/10428194.2019.1577414

https://www.ncbi.nlm.nih.gov/pubmed/30773115 (ανοίγει νέο παράθυρο)

Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trial. (ανοίγει νέο παράθυρο)

Platzbecker U, Wong RS, Verma A, Abboud C, Araujo S, Chiou TJ, Feigert J, Yeh SP, Götze K, Gorin NC, Greenberg P, Kambhampati S, Kim YJ, Lee JH, Lyons R, Ruggeri M, Santini V, Cheng G, Jang JH, Chen CY, Johnson B, Bennett J, Mannino F, Kamel YM, Stone N, Dougherty S, Chan G, Giagounidis A.

Πηγή‎: Lancet Haematol 2015;2(10):e417-26.

Καταχώριση‎: PubMed 26686043

https://www.ncbi.nlm.nih.gov/pubmed/26686043 (ανοίγει νέο παράθυρο)

Romiplostim for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation. (ανοίγει νέο παράθυρο)

Poon LM, Di Stasi A, Popat U, Champlin RE, Ciurea SO.

Πηγή‎: Am J Blood Res 2013;3(3):260-4.

Καταχώριση‎: PubMed 23997988

https://www.ncbi.nlm.nih.gov/pubmed/23997988 (ανοίγει νέο παράθυρο)

Safety and efficacy of eltrombopag in post-hematopoietic stem cell transplantation (HSCT) thrombocytopenia. (ανοίγει νέο παράθυρο)

Raut SS, Shah SA, Sharanangat VV, Shah KM, Patel KA, Anand AS, Talati SS, Panchal HP, Patel AA, Parikh SK, Shukla SN.

Πηγή‎: Indian J Hematol Blood Transfus 2015;31(4):413-5.

Καταχώριση‎: PubMed 26306064

DOI‎: 10.1007/s12288-014-0491-0

https://www.ncbi.nlm.nih.gov/pubmed/26306064 (ανοίγει νέο παράθυρο)

Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods. (ανοίγει νέο παράθυρο)

Reese JA, Li X, Hauben M, Aster RH, Bougie DW, Curtis BR, George JN, Vesely SK.

Πηγή‎: Blood 2010;116(12):2127-33.

Καταχώριση‎: PubMed 20530792

DOI‎: 10.1182/blood-2010-03-276691

https://www.ncbi.nlm.nih.gov/pubmed/20530792 (ανοίγει νέο παράθυρο)

Eltrombopag inhibits the proliferation of leukemia cells via reduction of intracellular iron and induction of differentiation. (ανοίγει νέο παράθυρο)

Roth M, Will B, Simkin G, Narayanagari S, Barreyro L, Bartholdy B, Tamari R, Mitsiades CS, Verma A, Steidl U.

Πηγή‎: Blood 2012;120(2):386-94.

Καταχώριση‎: PubMed 22627766

DOI‎: 10.1182/blood-2011-12-399667

https://www.ncbi.nlm.nih.gov/pubmed/22627766 (ανοίγει νέο παράθυρο)

Subcutaneous or intravenous administration of romiplostim in thrombocytopenic patients with lower risk myelodysplastic syndromes. (ανοίγει νέο παράθυρο)

Sekeres MA, Kantarjian H, Fenaux P, Becker P, Boruchov A, Guerci-Bresler A, Hu K, Franklin J, Wang YM, Berger D.

Πηγή‎: Cancer 2011;117(5):992-1000.

Καταχώριση‎: PubMed 20945323

DOI‎: 10.1002/cncr.25545

https://www.ncbi.nlm.nih.gov/pubmed/20945323 (ανοίγει νέο παράθυρο)

Romiplostim treatment of chemotherapy-induced thrombocytopenia. (ανοίγει νέο παράθυρο)

Soff GA, Miao Y, Bendheim G, Batista J, Mones JV, Parameswaran R, Wilkins CR, Devlin SM, Abou-Alfa GK, Cercek A, Kemeny NE, Sarasohn DM, Mantha S

Πηγή‎: J Clin Oncol 2019;37(31):2892-8.

Καταχώριση‎: PubMed 31545663

DOI‎: 10.1200/JCO.18.01931

https://www.ncbi.nlm.nih.gov/pubmed/31545663 (ανοίγει νέο παράθυρο)

Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans. (ανοίγει νέο παράθυρο)

Stohlawetz PJ, Dzirlo L, Hergovich N, Lackner E, Mensik C, Eichler HG, Kabrna E, Geissler K, Jilma B.

Πηγή‎: Blood 2000;95(9):2983-9.

Καταχώριση‎: PubMed 10779449

https://www.ncbi.nlm.nih.gov/pubmed/10779449 (ανοίγει νέο παράθυρο)

A pilot phase I dose finding safety study of the thrombopoietin-receptor agonist, eltrombopag, in patients with myelodysplastic syndrome treated with azacitidine. (ανοίγει νέο παράθυρο)

Svensson T, Chowdhury O, Garelius H, Lorenz F, Saft L, Jacobsen SE, Hellström-Lindberg E, Cherif H.

Πηγή‎: Eur J Haematol 2014;93(5):439-45.

Καταχώριση‎: PubMed 24853277

DOI‎: 10.1111/ejh.12383

https://www.ncbi.nlm.nih.gov/pubmed/24853277 (ανοίγει νέο παράθυρο)

Eltrombopag for treatment of thrombocytopenia after allogeneic hematopoietic cell transplantation. (ανοίγει νέο παράθυρο)

Tanaka T, Inamoto Y, Yamashita T, Fuji S, Okinaka K, Kurosawa S, Kim SW, Tanosaki R, Fukuda T.

Πηγή‎: Biol Blood Marrow Transplant 2016;22(5):919-24.

Καταχώριση‎: PubMed 26785333

DOI‎: 10.1016/j.bbmt.2016.01.018

https://www.ncbi.nlm.nih.gov/pubmed/26785333 (ανοίγει νέο παράθυρο)

Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experience. (ανοίγει νέο παράθυρο)

Tsimberidou AM, Giles FJ, Khouri I, Bueso-Ramos C, Pilat S, Thomas DA, Cortes J, Kurzrock R.

Πηγή‎: Ann Oncol 2005;16(1):139-45.

Καταχώριση‎: PubMed 15598951

DOI‎: 10.1093/annonc/mdi007

https://www.ncbi.nlm.nih.gov/pubmed/15598951 (ανοίγει νέο παράθυρο)

A randomized, double-blind, placebo-controlled phase 2 study evaluating the efficacy and safety of romiplostim treatment of patients with low or intermediate-1 risk myelodysplastic syndrome receiving lenalidomide. (ανοίγει νέο παράθυρο)

Wang ES, Lyons RM, Larson RA, Gandhi S, Liu D, Matei C, Scott B, Hu K, Yang AS.

Πηγή‎: J Hematol Oncol 2012;5:71.

Καταχώριση‎: PubMed 23190430

DOI‎: 10.1186/1756-8722-5-71

https://www.ncbi.nlm.nih.gov/pubmed/23190430 (ανοίγει νέο παράθυρο)

Romiplostim for chemotherapy-induced thrombocytopenia: efficacy and safety of extended use. (ανοίγει νέο παράθυρο)

Wilkins CR, Ortiz J, Gilbert LJ, Yin S, Mones JV, Parameswaran R, Mantha S, Soff GA

Πηγή‎: Res Pract Thromb Haemost. 2022;6(3):e12701.

Καταχώριση‎: PubMed 35582038

DOI‎: 10.1002/rth2.12701

https://pubmed.ncbi.nlm.nih.gov/35582038/ (ανοίγει νέο παράθυρο)

Effect of the nonpeptide thrombopoietin receptor agonist eltrombopag on bone marrow cells from patients with acute myeloid leukemia and myelodysplastic syndrome. (ανοίγει νέο παράθυρο)

Will B, Kawahara M, Luciano JP, Bruns I, Parekh S, Erickson-Miller CL, Aivado MA, Verma A, Steidl U.

Πηγή‎: Blood 2009;114(18):3899-908.

Καταχώριση‎: PubMed 19710504

DOI‎: 10.1182/blood-2009-04-219493

https://www.ncbi.nlm.nih.gov/pubmed/19710504 (ανοίγει νέο παράθυρο)